HC Wainwright Has Optimistic View of Spectral AI Q1 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for Spectral AI in a research note issued on Wednesday, April 2nd. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($0.09) per share for the quarter, up from their previous forecast of ($0.20). HC Wainwright has a “Buy” rating and a $3.50 price objective on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Spectral AI’s Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($0.43) EPS, FY2027 earnings at $0.40 EPS and FY2028 earnings at $0.02 EPS.

Spectral AI (NASDAQ:MDAI) last released its quarterly earnings data on Thursday, March 27th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.07. The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.83 million.

Spectral AI Stock Performance

NASDAQ MDAI opened at $1.21 on Monday. The firm’s fifty day moving average price is $1.69 and its two-hundred day moving average price is $1.68. The stock has a market cap of $28.13 million, a PE ratio of -1.86 and a beta of 0.62. Spectral AI has a fifty-two week low of $0.82 and a fifty-two week high of $3.25.

Institutional Investors Weigh In On Spectral AI

Hedge funds and other institutional investors have recently bought and sold shares of the company. Virtu Financial LLC bought a new stake in shares of Spectral AI during the fourth quarter worth about $38,000. Northern Trust Corp acquired a new stake in Spectral AI during the 4th quarter worth approximately $44,000. Millington Financial Advisors LLC bought a new stake in Spectral AI during the 4th quarter worth approximately $85,000. Jane Street Group LLC acquired a new position in Spectral AI in the 4th quarter valued at approximately $92,000. Finally, Renaissance Technologies LLC bought a new position in shares of Spectral AI during the fourth quarter valued at $272,000. Institutional investors own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.